Pharmaceutical Companies Under Scrutiny Over Tylenol Claims
Pharmaceutical companies are facing increasing scrutiny after public comments from President Donald Trump and Secretary of Health and Human Services Secretary Robert F. Kennedy Jr. hinted at a possible connection between Tylenol and autism. This comes over a month after those statements.
In Texas, Attorney General Ken Paxton has initiated legal action against Johnson & Johnson and KenVu, alleging that they have hidden information about the potential risks of prenatal acetaminophen use, which may be linked to autism spectrum disorder and attention deficit hyperactivity disorder. Acetaminophen is, of course, the main ingredient in Tylenol.
The lawsuit presents two major allegations against the companies. First, it claims that the defendants “failed to pay attention to scientific fact,” suggesting they downplayed or obscured existing research connecting acetaminophen to autism and ADHD. The implication here is that had the companies been more forthcoming on their labels, expectant mothers might have opted to avoid the medication entirely.
The complaint cites 26 epidemiological studies that reportedly show a “positive association” between prenatal acetaminophen usage and both ASD and ADHD, including research indicating a dose-response relationship.
The second part of the suit contends that Johnson & Johnson understood the potential legal implications of their products. The company allegedly attempted to evade liability by shifting Tylenol’s related responsibilities to Kenvue without transferring essential assets.
A representative for Johnson & Johnson addressed the lawsuit, stating, “Johnson & Johnson sold its consumer health business several years ago, and all rights and responsibilities… related to over-the-counter products containing Tylenol are owned by Johnson & Johnson.”
Paxton expressed strong opinions on the matter, claiming, “Big Pharma has betrayed America by profiting from pain and marketing drugs that ignore the risks.” He added that it seems Johnson & Johnson is attempting to skirt accountability by transferring blame. “By holding Big Pharma accountable for poisoning our people, we will help make America healthy again,” he said.
On the other hand, Kenvue released a statement clarifying its position. The company asserted, “Nothing is more important to us than the health and safety of those who use our products,” firmly disagreeing with the allegations and emphasizing a belief in the safety of acetaminophen. They stated that they would vigorously defend these claims and maintain that the lawsuit lacks a solid legal basis and scientific backing.
While Blaze News sought comments from Paxton’s office, there has been no response thus far.
